Home > Consumer Goods & Services > Personal Care > Skin Care > Lip Injection Market

Lip Injection Market Share

Report ID: GMI12114
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Lip Injection Market Share

In 2023, key companies like Allergan (AbbVie Inc.), Galderma, Medytox, Merz Pharma, REVANCE AESTHETICS held a combined market share of 75-80%. These companies are actively engaging in mergers, acquisitions, facility expansions, and collaborations to enhance their product portfolios, reach more customers, and strengthen their market positions.

Companies are heavily investing in research and development to develop advanced lip injection that align with the changing and evolving consumer’s needs and preferences. Competitive strategies frequently center on product differentiation, where manufacturers augment their offerings with distinctive features, and geographic expansion to penetrate emerging markets.

Lip Injection Market Companies

Major players operating in the lip injection industry are:

Allergan
Bioplus
Galderma
Hugel
Hyamed
Ipsen
Medtox
Merz Pharma
Revance Aesthetics
Sinclair
Suneva Medical
Vivacy

Authors: Avinash Singh, Sunita Singh

Frequently Asked Questions (FAQ) :

The global lip injection industry was valued at USD 3.18 billion in 2023 and is estimated to grow at a CAGR of over 7.3% from 2024 to 2032, driven by the increasing demand for cosmetic procedures.

The hyaluronic acid fillers segment recorded USD 1.19 billion in 2023 and is expected to grow at a CAGR of around 8.6% from 2024 to 2032 due to their safety and effectiveness in providing natural-looking results.

The U.S. holds approximately 76% of the North American lip injection market share, driven by a well-established culture of beauty enhancement and diverse beauty ideals.

Key players in the industry include Allergan, Bioplus, Galderma, Hugel, Hyamed, Ipsen, Medtox, Merz Pharma, Revance Aesthetics, and Sinclair.